No7

A television program, not a marketing department, turned this label into a phenomenon. In spring 2007, a BBC science show aired independent confirmation that an inexpensive Protect & Perfect serum measurably improved photo-aged skin. Shelves emptied across Britain within hours, waiting lists ran into the tens of thousands, and bottles costing under twenty pounds resurfaced online at steep markups. The chaos was real, and so was the data behind it.

The scientific credibility traces to an unusually patient academic relationship. Professor Chris Griffiths, a Manchester dermatologist, was openly skeptical when first asked to trial the serum. Biopsies changed his mind: the formula boosted fibrillin-1, a protein in skin's elastic scaffolding, marking the first time a cosmetic had been shown to improve sun-damaged skin in that specific structural way. That partnership has now run more than two decades, carrying through later peptide work including the Future Renew range built around damage-reversal claims.

The origin, though, was far humbler than the 2007 frenzy. The line debuted in Nottingham during economic depression as a full eleven-product skincare set, stocked only in the largest stores, with color cosmetics arriving two years on. Its founding idea was quietly egalitarian for the 1930s: serious skincare should belong to ordinary women, not only the affluent. A less-publicized program trains in-store advisors to help people navigating cancer treatment, a genuinely admirable thread rarely surfaced in advertising.

The honest read is that putting hero products through externally published clinical testing remains rare for a mass-market name and earns real credit. Keep proportions in mind, though. Peptide effects are gradual and modest, the visible payoff cumulative rather than dramatic, and promotional talk of deep penetration outruns the evidence. As drugstore-tier value backed by actual research, it stays one of the smarter buys on the aisle.

Sources:[1][2]